ISCONOVA AB has a total of 48 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are NOVARX, Novavax AB and ONYVAX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 5 | |
#4 | Brazil | 5 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | New Zealand | 4 | |
#7 | Sweden | 4 | |
#8 | South Africa | 4 | |
#9 | China | 3 | |
#10 | United States | 3 | |
#11 | Republic of Korea | 2 | |
#12 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Morein Bror | 40 |
#2 | Loevgren Bengtsson Karin | 14 |
#3 | Ranlund Katarina | 12 |
#4 | Ekstroem Jill | 8 |
#5 | Loevgren-Bengtsson Karin | 6 |
#6 | Osterhaus A D M E | 6 |
#7 | Fromgren Birgitta | 6 |
#8 | Lovgren Bengtsson Karin | 5 |
#9 | Baschunan Carlos | 5 |
#10 | Kaastrup Peter | 4 |
Publication | Filing date | Title |
---|---|---|
CN103052401A | Influenza vaccine | |
AU2010269148A1 | New composition | |
WO2006078213A1 | Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide | |
AU2004254152A1 | Quil a fraction with low toxicity and use thereof | |
AU2004224487A1 | Composition comprising iscom particles and live micro-organisms | |
EP1539231A1 | Iscom preparation and use thereof |